Metraipolis › archive › dc_e702a34926ea

Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in chronic kidney disease: an updated… — Europe PMC PMID:41430169

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41430169
DOI: 10.1186/s12882-[numero omesso]-2
License (as archived): solo-consultazione
Archived: 2026-11-07T11:28:36.641Z
SHA-256 of the archived text: 0baed85b03703132e37938f40367d6294263888acc722ac8a5d686c3a1c1c93a
Stable URL of this page: https://metraipolis.com/documento/dc_e702a34926ea

How to cite

Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in chronic kidney disease: an updated… — Europe PMC PMID:41430169 — Europe PMC (en), https://europepmc.org/article/MED/41430169 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e702a34926ea (Metraipolis archive dc_e702a34926ea, sha256 0baed85b03703132e37938f40367d6294263888acc722ac8a5d686c3a1c1c93a)

BibTeX

@misc{dce702a34926ea,
  title = {Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in chronic kidney disease: an updated… — Europe PMC PMID:41430169},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41430169},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e702a34926ea; sha256 0baed85b03703132e37938f40367d6294263888acc722ac8a5d686c3a1c1c93a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41430169. Agents can read the archived copy with the MCP tool read_document.